Skip to main content
logo
PD-Rx Pharmaceuticals, Inc. (PDRX)
OTCMKTS · Delayed Price · Currency is USD
3.350
0.00 (0.00%)
At close: May 12, 2026

PD-Rx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
18.3518.3518.9521.2728.7221.6
Revenue Growth
-15.06%-3.16%-10.93%-25.92%32.93%2.74%
Gross Profit
5.435.435.626.7111.066.96
Operating Income
-0.48-0.48-0.95-0.1940.88
Net Income
-0.26-0.26-0.75-0.13.031.86
Earnings Per Share
-0.16-0.16-0.46-0.061.831.08
EPS Growth
----69.44%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
6.176.175.46.835.472.9
Total Debt
------
Net Cash (Debt)
6.176.175.46.835.472.9
Net Cash Growth
112.26%14.11%-20.93%24.87%88.38%15.14%
Net Cash Per Share
3.833.833.304.183.301.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
0.770.77-1.351.793.24-0.47
Capital Expenditures
-0-0-0.08-0.43-0.55-0.11
Free Cash Flow
0.760.76-1.431.362.69-0.57
Free Cash Flow Growth
----49.28%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
29.61%29.61%29.68%31.56%38.52%32.20%
Operating Margin
-2.60%-2.60%-5.03%-0.90%13.94%4.06%
Pretax Margin
-1.52%-1.52%-3.76%-0.60%14.11%8.49%
Profit Margin
-1.40%-1.40%-3.98%-0.46%10.57%8.59%
FCF Margin
4.16%4.16%-7.54%6.40%9.35%-2.66%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
----1.762.63
P/FCF Ratio
7.225.20-7.251.99-
PS Ratio
0.300.220.350.460.190.23